54 results
Page 2 of 3
6-K
EX-99.1
oa5tullakjvabvpx06
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
sw7nb2
6 Aug 21
Prospectus supplement
8:17am
424B3
xd26wv u96b63f
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
5ml3qyl9udz0kj5m44
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
j46w4 full65lrl8i4s
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
nvd8i0e yf9z59
2 Jun 21
Prospectus supplement
10:10am
424B3
08o8fdy7j j6h7x
2 Jun 21
Prospectus supplement
10:09am
424B3
11i0smsheyk
2 Jun 21
Prospectus supplement
10:08am
425
trt c5xgzn2
5 May 21
Business combination disclosure
5:26pm
425
j3ywhd7leqpzr0b1
5 May 21
Business combination disclosure
5:25pm
425
dqabpuhu41ki 2o
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
g2h971x7 1k9sjojx
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
07l cx7883i03qvzef8
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
wrx5 ly7d
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
ykvuaxo b8m
30 Apr 21
Annual report (foreign)
12:53pm
424B3
gisa g2kln
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
kqs644qzbeljfz9a7
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
tm540cd1km2o16s81
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
h7po tddfyyvjj
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
reenk
8 Jan 21
Registration statement (foreign)
4:58pm